Elite Financial Statements From 2010 to 2024
| ELTPDelisted Stock | USD 0.14 0.00 0.00% |
Check Elite Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elite main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Elite financial statements analysis is a perfect complement when working with Elite Pharma Valuation or Volatility modules.
Elite |
Elite Pharma OTC Stock Operating Margin Analysis
Elite Pharma's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Elite Pharma Operating Margin | 0.15 % |
Most of Elite Pharma's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elite Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Elite Pharma has an Operating Margin of 0.1455%. This is 100.41% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The operating margin for all United States stocks is 102.64% lower than that of the firm.
Elite Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elite Pharma's current stock value. Our valuation model uses many indicators to compare Elite Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elite Pharma competition to find correlations between indicators driving Elite Pharma's intrinsic value. More Info.Elite Pharma is one of the top stocks in return on equity category among related companies. It is one of the top stocks in return on asset category among related companies reporting about 0.27 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Elite Pharma is roughly 3.71 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Elite Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Elite Pharma's OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elite Pharma's earnings, one of the primary drivers of an investment's value.About Elite Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Elite Pharma income statement, its balance sheet, and the statement of cash flows. Elite Pharma investors use historical funamental indicators, such as Elite Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Elite Pharma investors may use each financial statement separately, they are all related. The changes in Elite Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Elite Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Elite Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Elite Pharma. Please read more on our technical analysis and fundamental analysis pages.
Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Elite Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Elite Pharma's short interest history, or implied volatility extrapolated from Elite Pharma options trading.
Pair Trading with Elite Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Elite Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elite Pharma will appreciate offsetting losses from the drop in the long position's value.Moving together with Elite OTC Stock
| 0.61 | DRRX | Durect Financial Report 13th of May 2024 | PairCorr |
Moving against Elite OTC Stock
| 0.78 | DVAX | Dynavax Technologies Earnings Call This Week | PairCorr |
| 0.73 | ETON | Eton Pharmaceuticals Financial Report 9th of May 2024 | PairCorr |
| 0.61 | EVOK | Evoke Pharma | PairCorr |
| 0.53 | SBFMW | Sunshine Biopharma | PairCorr |
| 0.45 | EVO | Evotec SE ADR Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Elite Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Elite Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Elite Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Elite Pharma to buy it.
The correlation of Elite Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Elite Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Elite Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Elite Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Elite OTC Stock
If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |